<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41482-bib-0019">
 <label>19</label>
 <mixed-citation publication-type="journal" id="hep41482-cit-0019">
  <string-name>
   <surname>Falade‐Nwulia</surname>
   <given-names>O</given-names>
  </string-name>, 
  <string-name>
   <surname>Suarez‐Cuervo</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Nelson</surname>
   <given-names>DR</given-names>
  </string-name>, 
  <string-name>
   <surname>Nelson</surname>
   <given-names>DR</given-names>
  </string-name>, 
  <string-name>
   <surname>Fried</surname>
   <given-names>MW</given-names>
  </string-name>, 
  <string-name>
   <surname>Segal</surname>
   <given-names>JB</given-names>
  </string-name>, et al. 
  <article-title>Oral direct‐acting agent therapy for hepatitis C virus infection: a systematic review</article-title>. 
  <source xml:lang="en">Ann Intern Med</source>
  <year>2017</year>;
  <volume>166</volume>:
  <fpage>637</fpage>‐
  <lpage>648</lpage>.
  <pub-id pub-id-type="pmid">28319996</pub-id>
 </mixed-citation>
</ref>
